Skip to main content
. 2006 Nov 9;66(4):470–475. doi: 10.1136/ard.2006.057885

graphic file with name ar57885.f3.jpg

Figure 3 Changes in expression of functional molecules on CD4‐positive cells induced by rituximab treatment. The expression of CD40L (patient 2), CD69 (patient 6) and ICOS (patient 7) on CD4‐positive cells was measured before (day 0) and 28 days after rituximab treatment. Percentages represent the percentage of CD4‐positive cells expressing the functional molecules.